Loading...

Khimprom

MISX:HIMCP
Snowflake Description

Proven track record and slightly overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
HIMCP
MISX
RUB682M
Market Cap
  1. Home
  2. RU
  3. Materials
Company description

Khimprom Public joint stock company engages in the manufacture and sale of various chemical products in Russia and internationally. The last earnings update was 234 days ago. More info.


Add to Portfolio Compare Print
HIMCP Share Price and Events
7 Day Returns
-3%
MISX:HIMCP
0.5%
RU Chemicals
0.2%
RU Market
1 Year Returns
6.7%
MISX:HIMCP
7.2%
RU Chemicals
8%
RU Market
HIMCP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Khimprom (HIMCP) -3% -3% 5.9% 6.7% 448.5% 364.3%
RU Chemicals 0.5% -0.9% 1.6% 7.2% 3.3% 97.4%
RU Market 0.2% 1.7% 3.1% 8% 30.8% 97.1%
1 Year Return vs Industry and Market
  • HIMCP underperformed the Market in Russian Federation which returned 8% over the past year.
Price Volatility
HIMCP
Industry
5yr Volatility vs Market

HIMCP Value

 Is Khimprom undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Khimprom to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Khimprom.

MISX:HIMCP Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 27.3%
Perpetual Growth Rate 10-Year RU Government Bond Rate 8.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for MISX:HIMCP
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year RU Govt Bond Rate 8.4%
Equity Risk Premium S&P Global 9.4%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.93
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.93 (1 + (1- 20%) (687.58%))
4.382
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 8.44% + (2 * 9.43%)
27.3%

Discounted Cash Flow Calculation for MISX:HIMCP using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Khimprom is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

MISX:HIMCP DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (RUB, Millions) Source Present Value
Discounted (@ 27.3%)
2019 1,065.14 Est @ 85.45% 836.71
2020 1,729.22 Est @ 62.35% 1,067.07
2021 2,527.69 Est @ 46.18% 1,225.29
2022 3,408.71 Est @ 34.85% 1,298.00
2023 4,326.68 Est @ 26.93% 1,294.23
2024 5,251.86 Est @ 21.38% 1,234.08
2025 6,170.95 Est @ 17.5% 1,139.08
2026 7,083.15 Est @ 14.78% 1,027.07
2027 7,995.42 Est @ 12.88% 910.72
2028 8,918.71 Est @ 11.55% 798.03
Present value of next 10 years cash flows RUB10,830.29
MISX:HIMCP DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= RUB8,918.71 × (1 + 8.44%) ÷ (27.3% – 8.44%)
RUB51,280.21
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= RUB51,280.21 ÷ (1 + 27.3%)10
RUB4,588.45
MISX:HIMCP Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= RUB10,830.29 + RUB4,588.45
RUB15,418.73
Equity Value per Share
(RUB)
= Total value / Shares Outstanding
= RUB15,418.73 / 688.89
RUB22.38
MISX:HIMCP Discount to Share Price
Calculation Result
Value per share (RUB) From above. RUB22.38
Current discount Discount to share price of RUB6.50
= -1 x (RUB6.50 - RUB22.38) / RUB22.38
71%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Khimprom is available for.
Intrinsic value
>50%
Share price is RUB6.5 vs Future cash flow value of RUB22.38
Current Discount Checks
For Khimprom to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Khimprom's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Khimprom's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Khimprom's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Khimprom's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
MISX:HIMCP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in RUB Not available
MISX:HIMCP Share Price ** MISX (2019-04-19) in RUB RUB6.5
Russian Federation Chemicals Industry PE Ratio Median Figure of 6 Publicly-Listed Chemicals Companies 11.41x
Russian Federation Market PE Ratio Median Figure of 129 Publicly-Listed Companies 7.36x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Khimprom.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to compare the PE ratio to the industry average as no data exists.
  • Unable to calculate PE ratio for Khimprom, we can't compare the value of its earnings to the Russian Federation market.
Price based on expected Growth
Does Khimprom's expected growth come at a high price?
Raw Data
MISX:HIMCP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 0x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
9.9%per year
Europe Chemicals Industry PEG Ratio Median Figure of 62 Publicly-Listed Chemicals Companies 1.89x
Russian Federation Market PEG Ratio Median Figure of 33 Publicly-Listed Companies 0.51x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Khimprom, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Khimprom's assets?
Raw Data
MISX:HIMCP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in RUB Not available
MISX:HIMCP Share Price * MISX (2019-04-19) in RUB RUB6.5
Russian Federation Chemicals Industry PB Ratio Median Figure of 8 Publicly-Listed Chemicals Companies 2.48x
Russian Federation Market PB Ratio Median Figure of 149 Publicly-Listed Companies 0.82x

* Primary Listing of Khimprom.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to compare the PB ratio to the industry average as no data exists.
X
Value checks
We assess Khimprom's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Khimprom has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

HIMCP Future Performance

 How is Khimprom expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Khimprom, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Khimprom expected to grow at an attractive rate?
  • Khimprom's earnings growth is expected to exceed the low risk savings rate of 8.4%.
Growth vs Market Checks
  • Khimprom's earnings growth is expected to exceed the Russian Federation market average.
  • Unable to compare Khimprom's revenue growth to the Russian Federation market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
MISX:HIMCP Future Growth Rates Data Sources
Data Point Source Value (per year)
MISX:HIMCP Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 9.9%
Russian Federation Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 12.5%
Europe Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.6%
Russian Federation Market Earnings Growth Rate Market Cap Weighted Average 3.8%
Russian Federation Market Revenue Growth Rate Market Cap Weighted Average 4.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
MISX:HIMCP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in RUB Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
MISX:HIMCP Past Financials Data
Date (Data in RUB Millions) Revenue Cash Flow Net Income *
2018-06-30 12,382 1,400 947
2018-03-31 11,414 1,049 797
2017-12-31 10,446 699 647
2017-09-30 10,140 536 543
2017-06-30 9,835 373 487
2017-03-31 9,534 264 487
2016-12-31 9,233 155 488
2016-09-30 8,848 119 477
2016-06-30 8,464 82 418
2016-03-31 8,096 76 303
2015-12-31 7,729 69 188
2015-09-30 7,278 397 118

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Khimprom's earnings are expected to grow by 9.9% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Khimprom is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
MISX:HIMCP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Khimprom Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

MISX:HIMCP Past Financials Data
Date (Data in RUB Millions) EPS *
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30 0.71
2017-03-31 0.71
2016-12-31 0.71
2016-09-30 0.69
2016-06-30 0.61
2016-03-31 0.44
2015-12-31 0.27
2015-09-30 0.17

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Khimprom will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Khimprom's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Russian Federation market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Khimprom has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

HIMCP Past Performance

  How has Khimprom performed over the past 5 years?

  • Khimprom's last earnings update was 234 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Khimprom's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Khimprom has delivered over 20% year on year earnings growth in the past 5 years.
  • Khimprom's 1-year earnings growth exceeds its 5-year average (94.6% vs 62.7%)
  • Khimprom's earnings growth has exceeded the RU Chemicals industry average in the past year (94.6% vs -0.4%).
Earnings and Revenue History
Khimprom's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Khimprom Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

MISX:HIMCP Past Revenue, Cash Flow and Net Income Data
Date (Data in RUB Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 12,381.83 946.85 2,065.71
2018-03-31 11,413.79 797.12 1,997.73
2017-12-31 10,445.75 647.39 1,929.76
2017-09-30 10,140.44 542.66 1,808.00
2017-06-30 9,835.12 486.63 1,683.70
2017-03-31 9,534.07 487.14 1,603.77
2016-12-31 9,233.02 487.66 1,523.85
2016-09-30 8,848.50 477.35 1,451.41
2016-06-30 8,463.98 418.35 1,381.52
2016-03-31 8,096.33 303.40 1,319.84
2015-12-31 7,728.69 188.45 1,258.16
2015-09-30 7,277.66 117.57 1,217.47
2015-06-30 6,826.62 46.69 1,176.78
2015-03-31 6,443.88 24.63 1,163.49
2014-12-31 6,061.14 2.56 1,150.20
2014-09-30 5,987.81 -24.66 1,145.32
2014-06-30 5,914.48 -51.88 1,140.44
2014-03-31 5,801.53 -81.17 1,113.55
2013-12-31 5,688.58 -110.46 1,086.65
2013-09-30 5,715.19 -30.84 1,013.85
2013-06-30 5,651.48 81.57 1,043.35
2013-03-31 5,737.83 119.99 1,027.33
2012-12-31 5,777.46 184.00 1,005.23
2012-09-30 5,799.91 174.71 1,067.49
2012-06-30 5,949.51 260.36 977.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Whilst Khimprom has efficiently used shareholders’ funds last year (Return on Equity greater than 20%), this is metric is skewed due to its high level of debt.
  • Khimprom used its assets more efficiently than the RU Chemicals industry average last year based on Return on Assets.
  • Khimprom's use of capital has not improved over the past 3 years (Return on Capital Employed).
X
Past performance checks
We assess Khimprom's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Khimprom has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

HIMCP Health

 How is Khimprom's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Khimprom's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Khimprom's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Khimprom's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Khimprom's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Khimprom Company Filings, last reported 9 months ago.

MISX:HIMCP Past Debt and Equity Data
Date (Data in RUB Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 2,955.57 4,689.33 102.62
2018-03-31 2,955.57 4,689.33 102.62
2017-12-31 2,635.93 4,898.19 6.92
2017-09-30 2,635.93 4,898.19 6.92
2017-06-30 2,626.46 4,245.58 5.68
2017-03-31 2,626.46 4,245.58 5.68
2016-12-31 2,454.65 4,039.42 50.93
2016-09-30 2,454.65 4,039.42 50.93
2016-06-30 2,657.47 3,446.37 30.50
2016-03-31 2,657.47 3,446.37 30.50
2015-12-31 2,315.92 3,421.02 7.88
2015-09-30 2,315.92 3,421.02 7.88
2015-06-30 2,188.69 3,125.50 4.28
2015-03-31 2,188.69 3,125.50 4.28
2014-12-31 2,064.77 3,232.51 205.65
2014-09-30 2,064.77 3,232.51 205.65
2014-06-30 2,110.13 2,902.41 24.33
2014-03-31 2,110.13 2,902.41 24.33
2013-12-31 2,065.18 3,084.60 11.34
2013-09-30 2,065.18 3,084.60 11.34
2013-06-30
2013-03-31 2,235.91 2,192.03 22.70
2012-12-31 2,235.91 2,192.03 22.70
2012-09-30 2,289.31 2,386.49 125.76
2012-06-30 2,233.24 2,258.33 181.20
  • Khimprom's level of debt (158.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (122.8% vs 158.7% today).
  • Debt is well covered by operating cash flow (29.8%, greater than 20% of total debt).
  • Khimprom is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Khimprom's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Khimprom has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

HIMCP Dividends

 What is Khimprom's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
6.22%
Current annual income from Khimprom dividends.
If you bought RUB2,000 of Khimprom shares you are expected to receive RUB124 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Khimprom's pays a higher dividend yield than the bottom 25% of dividend payers in Russian Federation (3.25%).
  • Khimprom's dividend is below the markets top 25% of dividend payers in Russian Federation (9.15%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
MISX:HIMCP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Russian Federation Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 7 Stocks 10.6%
Russian Federation Market Average Dividend Yield Market Cap Weighted Average of 75 Stocks 6.8%
Russian Federation Minimum Threshold Dividend Yield 10th Percentile 1.8%
Russian Federation Bottom 25% Dividend Yield 25th Percentile 3.2%
Russian Federation Top 25% Dividend Yield 75th Percentile 9.2%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

MISX:HIMCP Past Annualized Dividends Data
Date (Data in RUB) Dividend per share (annual) Avg. Yield (%)
2017-11-02 0.404 6.361

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • It is too early to tell whether Khimprom has stable dividend payments.
  • Khimprom only just started paying a dividend, it is too early to tell if payments are increasing.
Current Payout to shareholders
What portion of Khimprom's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Khimprom has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Khimprom's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Khimprom afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Khimprom has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

HIMCP Management

 What is the CEO of Khimprom's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Sergey Nauman
TENURE AS CEO 0.8 years
CEO Bio

Sergey Nauman has been General Director of Khimprom Public joint stock company since July 1, 2018.

CEO Compensation
  • Insufficient data for Sergey to compare compensation growth.
  • Insufficient data for Sergey to establish whether their remuneration is reasonable compared to companies of similar size in .
Management Team

Sergey Nauman

TITLE
General Director
TENURE
0.8 yrs

Elena Kolesnikova

TITLE
Director of Economics & Finance

Yuri Efimov

TITLE
Technical Director & Director

Fedor Bastrygin

TITLE
Director of Legal Affairs

Igor Vladimirovich

TITLE
Director of Human Resources

Vitaly Vyasovoy

TITLE
First Deputy General Director

Mikhail Vorozhev

TITLE
Head of Sales - Organosilicon Products

Tatiana Tsvetkova

TITLE
Deputy Head of Foreign Economic Activity Department

Alexey Shevnitsyn

TITLE
Head of Sales - Products for Power Engineering

Dmitry Skuratov

TITLE
Head of Sales - Basic Products
Board of Directors Tenure

Average tenure of the Khimprom board of directors in years:

11.3
Average Tenure
  • The average tenure for the Khimprom board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Ivan Vorobyev

TITLE
Chairman
TENURE
7.8 yrs

Dmitriy Sizentsev

TITLE
Deputy Chairman
TENURE
7.8 yrs

Yuri Efimov

TITLE
Technical Director & Director

Dmitriy Mayorov

TITLE
Director
TENURE
11.8 yrs

Yuriy Voloshin

TITLE
Director
TENURE
11.3 yrs

Andrey Zaydenvarg

TITLE
Director
TENURE
11.3 yrs

Aleksandr Shumskiy

TITLE
Director
TENURE
11.3 yrs

Sergey Mikhaylov

TITLE
Director
TENURE
11.3 yrs

Yaroslav Kuznetsov

TITLE
Director
AGE
48
TENURE
11.3 yrs

Natalia Davydenko

TITLE
Director
AGE
49
TENURE
11.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (RUB) Value (RUB)
X
Management checks
We assess Khimprom's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Khimprom has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

HIMCP News

Simply Wall St News

Does Khimprom Public joint stock company (MCX:HIMCP)'s Capital Return Make The Cut?

and looking to gauge the potential return on investment in Khimprom Public joint stock company (MCX:HIMCP). … You need to pay attention to this because your return on investment is linked to dividends and internal investments to improve the business, which can only occur if the company is expected to produce adequate earnings with the capital that has been provided. … Therefore, looking at how efficiently Khimprom is able to use capital to create earnings will help us understand your potential return.

Simply Wall St -

HIMCP Company Info

Description

Khimprom Public joint stock company engages in the manufacture and sale of various chemical products in Russia and internationally. Its chemical products include organochlorous, organophosphorous, and organosilicon products, as well as household goods, herbicides and insecticides, and polyesters for rigid polyurethane foams. The company also offers ethylsilicate, methylene chloride, and complexones; hydrogen peroxide; acetonanil-N- antioxidant for rubber; softener-2 – monomer for heat resistant polymeric fibers; and phosphorus and chlorine containing fire retardants for polymeric materials. It serves enterprises in various industries, such as chemical, oil and gas, light, pulp and paper, wood-working, medical, pharmaceutical, electrical engineering, metallurgy, construction, heat and power engineering, machine building, and agriculture. The company was founded in 1960 and is based in Novocheboksarsk, Russia. Khimprom Public joint stock company is a subsidiary of OJSC Orgsyntez.

Details
Name: Khimprom Public joint stock company
HIMCP
Exchange: MISX
Founded: 1960
RUB682,005,263
688,894,206
Website: http://www.himprom.com
Address: Khimprom Public joint stock company
101 Promyshlennaya Street,
Novocheboksarsk,
Chuvashiya, 429952,
Russia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
MISX HIMCP RUB1 PRF(RUB) Micex - Rts RU RUB 21. Oct 2003
MISX HIMC Usual Shares Micex - Rts RU RUB 30. Jan 2007
Number of employees
Current staff
Staff numbers
0
Khimprom employees.
Industry
Commodity Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/19 21:46
End of day share price update: 2019/04/19 00:00
Last earnings filing: 2018/08/28
Last earnings reported: 2018/06/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.